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ABSTRACT
Purpose. To review records of 371 patients who 
underwent total hip or knee arthroplasty (THA 
or TKA) with intra-operative blood salvage to 
determine the allogeneic blood transfusion rate and 
the predictors for allogeneic blood transfusion. 
Methods. Records of 155 male and 216 female 
consecutive patients aged 17 to 95 (mean, 70) years 
who underwent primary THA or TKA by a single 
surgeon with the use of intra-operative blood salvage 
were reviewed. 
Results. The preoperative haemoglobin level was 
<120 g/dl in 15% of THA patients and 5% of TKA 
patients; the allogeneic transfusion rate was 24% 
in THA patients and 12% in TKA patients. Despite 
routine use of intra-operative blood salvage, only 59% 
of THA patients and 63% of TKA patients actually 
received salvaged blood, as a minimum of 200 ml 
blood loss was required to activate blood salvage. In 
multivariable analysis, predictors for allogeneic blood 
transfusion were female gender (adjusted odds ratio 
[OR]=2.8, p=0.02), age >75 years (adjusted OR=5.9, 
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p<0.001), and preoperative haemoglobin level <120 
g/l (adjusted OR=30.1, p<0.001), despite the use of 
intra-operative blood salvage. Patients who received 
allogeneic blood transfusion had a longer hospital 
stay and greater complication rate.
Conclusion. Intra-operative blood salvage is not 
effective in preventing allogeneic blood transfusion 
in patients with a preoperative haemoglobin level 
<120 g/l. It should be combined with preoperative 
optimisation of the haemoglobin level or use of 
tranexamic acid.
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introduction
Substantial peri-operative blood loss in total hip 
and knee arthroplasty (THA and TKA) may lead to 
postoperative anaemia and necessitate allogeneic 
blood transfusion, with the rate being 57% and 
39%, respectively.1 Total joint arthroplasty and 
fracture surgery account for most cases of allogeneic 
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blood transfusion, compared with other surgical 
specialties.2,3 Nonetheless, allogeneic blood transfusion 
is associated with risks of disease transmission, 
haemolytic reactions, immunomodulation, 
haemodynamic overload, acute lung injury, and 
coagulopathy.4 Patients who receive allogeneic blood 
have an increased risk of postoperative infection, 
longer hospital stay, and mortality.5–7 Various blood 
conservation strategies have been recommended. 
Nonetheless, preoperative autologous blood donation 
is not cost-effective and there is a high rate of unused 
blood.8–10 The effectiveness of acute normovolaemic 
haemodilution is debatable.11 Postoperative re-
transfusion may result in transfusion reactions, as 
unwashed blood contains fibrin degradation products 
and other contaminants.12,13 
 Intra-operative blood salvage re-transfuses 
washed blood that is removed of biochemical, cellular, 
and non-cellular debris including activated clotting 
factors, fatty lipids, and bone, and results in minimal 
disruption to surgical workflow.14,15 Intra-operative 
blood salvage has been reported to decrease the 
allogeneic blood transfusion rate varying from 57%1 
to 6%,16 8%,17 and 15%18 in THA, and from 39%1 to 
7%,19 11%,20 and 16%21 in TKA. This study reviewed 
records of 371 patients who underwent THA or TKA 
with intra-operative blood salvage to determine the 
allogeneic blood transfusion rate and the predictors 
for allogeneic blood transfusion. 
Materials and Methods
This study was approved by our hospitals’ regional 
ethics committee. The proportion of patients who 
would require blood transfusion was assumed to be 
20%, and thus 246 patients were required to obtain a 
95% confidence interval (CI) with a maximum error of 
0.05. Records of 155 male and 216 female consecutive 
patients aged 17 to 95 (mean, 70) years who 
underwent primary THA (n=135) or TKA (n=236) by 
a single surgeon from January 2010 to December 2011 
(prior to the introduction of tranexamic acid) with the 
use of intra-operative blood salvage were reviewed. 
 THA was performed through an anterolateral 
approach with the patient in a lateral position. 
Uncemented acetabular and femoral components 
were used (Exceed acetabular cup Taperloc femoral 
stem, Biomet, Warsaw [IN], USA); no drain was used. 
TKA was performed through a standard medial para-
patellar approach without tourniquet use. Computer 
navigation was used for alignment and preparation. 
Cemented femoral, tibial, and patellar components 
were used (Legion Primary, Smith and Nephew, 
Memphis [TE], USA). An intra-articular drain on low 
suction was removed on day 1. All patients received 
enoxaparin 40 mg daily for venous thromboembolic 
prophylaxis, commencing 4 hours postoperatively 
and continued for 14 days for TKA and 28 days for 
THA. Aspirin was continued throughout the peri-
operative period if it was already prescribed.
 Using the Haemonetics Cell Saver 5+ machine 
(Braintree [MA], USA), salvaged blood was washed 
and concentrated prior to re-transfusion in the 
recovery room. Haemoglobin level was checked 
on postoperative day 1. The transfusion trigger 
was patient-specific, based on the guidelines of the 
National Blood Authority of Australia. An absolute 
trigger was a haemoglobin level <80 g/l. Patients with 
symptomatic anaemia and significant comorbidities 
may be given transfusion at a haemoglobin level 
<100 g/l,22 based on the surgeon’s decision.
 Binary variables were presented in proportion; 
normally distributed variables were presented as 
mean±standard deviation and compared using 
independent t-test; non–normally distributed 
variables were presented as median and inter-quartile 
range and compared using Mann-Whitney U test; 
discrete variables were presented as percentages and 
compared using Pearson Chi-squared test. Univariate 
and multivariate analyses were used to determine 
predictors for allogeneic blood transfusion, a p 
value of ≤0.10 and <0.05 was considered significant, 
respectively.
results
The preoperative haemoglobin level was <120 g/dl 
in 15% of THA patients and 5% of TKA patients; the 
allogeneic transfusion rate was 24% in THA patients 
and 12% in TKA patients (Table 1). Despite routine 
use of intra-operative blood salvage, only 59% of 
THA patients and 63% of TKA patients actually 
received salvaged blood, as a minimum of 200 ml 
blood loss was required to activate blood salvage. 
Only 9 patients who did not receive salvaged blood 
had blood loss >200 ml. Intra-operative blood loss 
was greater in patients who received salvaged blood 
than in those who did not (362.48 vs. 156.15 ml, 
p<0.001, Table 2). 
 Compared with patients who did not receive 
allogeneic blood transfusion, those who did had a 
lower preoperative haemoglobin level (139.61 vs. 
122.76 g/l, p<0.001), less blood loss (290 vs. 245 ml, 
p=0.03), lower rate of re-transfusion of salvaged 
blood (64% vs. 48%, p=0.02), lower postoperative 
haemoglobin level (121.65 vs. 103.46 g/l, p<0.001), 
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longer hospital stay (5 vs. 6 days, p=0.01), and higher 
complication rate (15% vs. 48%, p<0.001) [Table 3].
 In univariate analysis, main predictors for 
allogeneic blood transfusion were female gender 
(odds ratio [OR]=3.5, p<0.001), age >75 years 
(OR=5.2, p<0.001), THA (OR=2.3, p=0.004), and 
preoperative haemoglobin level <120 g/l (OR=44.4, 
p<0.001) [Table 4]. In multivariate analysis, predictors 
for allogeneic blood transfusion were female gender 
(adjusted OR=2.8, p=0.02), age >75 years (adjusted 
OR=5.9, p<0.001), and preoperative haemoglobin 
level <120 g/l (adjusted OR=30.1, p<0.001), despite 
the use of intra-operative blood salvage (Table 4). 
All 4 patients with a body mass index <20 kg/m2 
required allogeneic blood transfusion. THA was no 
longer a predictor for allogeneic blood transfusion, 
as this group had more percentage of patients with 
a preoperative haemoglobin level <120 g/dl and 
female gender.
discussion
Intra-operative blood salvage avoids problems 
with the storage of pre-donated autologous blood 
and allogeneic blood transfusion, and enables re-
transfusion of more efficacious oxygen-carrying 
red blood cells that have a higher erythrocyte 
viability23 and increased preservation of 2-3 
diphosphoglycerate.24 It also removes contaminants 
and concentrates the re-transfusion volume. 
 In our study, patients who underwent THA were 
* Data are presented as no. (%) of patients or median (range)
† Only 79 and 149 total hip and knee arthroplasty patients actually received salvage blood, respectively
Parameter Total (n=371) Total hip arthroplasty 
(n=135)
Total knee arthroplasty 
(n=236)
Female 216 (58) 86 (63) 130 (55)
Age >75 years 101 (27) 39 (29) 62 (26)
Age (years) 70 (17–95) 70 (17–91) 70 (47–95)
Body mass index (kg/m2) 29.2 (15.7–52.2) 27.4 (15.7–43.8) 30.3 (18.5–52.2)
Body mass index (kg/m2) category
<20 4 (1) 3 (2) 1 (<1)
20–25 77 (21) 47 (35) 30 (13)
26–30 143 (39) 45 (33) 98 (42)
>30 147 (40) 40 (30) 107 (45)
Diagnosis
Osteoarthritis 349 (94) 119 (88) 230 (97)
Inflammatory 6 (2) 2 (1) 4 (2)
Other 16 (4) 14 (10) 2 (1)
Preop haemoglobin (g/l) 137 (72–177) 134 (72–170) 138 (103–177)
Preop haemoglobin (g/l) category
≥150 83 (22) 20 (15) 63 (27)
120–150 257 (69) 95 (70) 162 (69)
<120 31 (8) 20 (15) 11 (5)
Allogeneic blood transfusion 61 (16) 32 (24) 29 (12)
Whole blood loss (ml) 283 (50–1200) 271 (50–1200) 290 (100–950)
Re-transfusion of salvaged blood 228 (61) 79 (59) 149 (63)
Salvaged blood volume (ml)† 197 (10–890) 205 (40–890) 193 (10–650)
Haemoglobin drop until day 0 (g/l) 18.3 (-34–47) 17.7 (-34–40) 18.7 (-12–47)
Haemoglobin drop until day 1 (g/l) 28.4 (-29–56) 27.3 (-29–53) 29.1 (6–56)
Knee drain volume (ml)  -  - 209 (0–800)
Any complication 74 (20) 29 (21) 45 (19)
Length of hospital stay (days) 6 (3–30) 6 (3–16) 6 (3–30)
Table 1
Patient characteristics and outcome*
Parameter Received salvaged blood 
(n=228)
Not received salvaged 
blood (n=143)
Mean difference 
(95% CI)
p Value
Preop haemoglobin (g/l) 137.40±14.03 135.85±12.76 1.6 (-1.4–4.5) 0.30
Intra-operative blood loss (ml) 362.48±136.69 (200–1200) 156.15±52.06 (50–350) 206.3 (182.8–229.8) <0.001
Table 2
Comparison of patients who did or did not receive intra-operative salvaged blood in terms of preoperative haemoglobin 
level and intra-operative blood loss
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* All 4 patients with a BMI <20 kg/m2 required allogeneic blood transfusion
Predictor OR (95% CI) p Value
Univariate analysis Crude
Female sex 3.5 (1.8–6.8) <0.001
Age >75 years 5.2 (2.9–9.2) <0.001
Total hip arthroplasty (vs. total knee arthroplasty) 2.3 (1.3–4.0) 0.004
Diagnosis of inflammatory condition (vs. osteoarthritis) 1.2 (0.1–10.1) 0.75
Diagnosis of other condition (vs. osteoarthritis) 4.62 (1.74–12.28) 0.002
Haemoglobin <120 g/l (vs. haemoglobin >150 g/l) 44.4 (12.8–154.3) <0.001
Haemoglobin 120–150 g/l (vs. haemoglobin >150 g/l) 2.5 (0.8–7.3) 0.21
Body mass index (BMI) <20 kg/m2 (vs. BMI 20–25 kg/m2)* - -
BMI 25–30 kg/m2 (vs. BMI 20–25 kg/m2) 0.34 (0.17–0.67) 0.002
BMI >30 kg/m2 (vs. BMI 20–25 kg/m2) 0.23 (0.11–0.48) <0.001
Multivariate analysis Adjusted
Female sex 2.8 (1.2–6.6) 0.02
Age >75 years 5.9 (2.9–12.1) <0.001
Haemoglobin <120 g/l (vs. haemoglobin >150 g/l) 30.1 (7.5–121.6) <0.001
Haemoglobin 120–150 g/l (vs. haemoglobin >150 g/l) 1.3 (0.4–4.1) 0.32
Table 4
Univariate and multivariate analyses for predictors for allogeneic blood transfusion
* Data are presented as mean±SD, no. (%), or median (interquartile range)
† In 27 and 197 total knee arthroplasty patients who did and did not receive allogeneic blood transfusion, respectively
Outcome Total (n=371) Allogeneic blood 
transfusion 
(n=61)
No allogeneic 
blood transfusion 
(n=310)
Difference (95% CI) p Value
Preop haemoglobin (g/l) 136.80±13.56 122.76±14.26 139.61±11.54 -16.9 (-13.5 to -20.2) <0.001
Whole blood loss (ml) 283±150 245±156 290±148 -45.6 (-4.4 to -86.8) 0.03
Received salvaged blood 228 (61) 29 (48) 199 (64) -16 (-3 to -30) 0.02
Salvaged blood volume (ml) 150 (135–250) 156 (130–270) 150 (135–250) 6 0.40
Haemoglobin drop until day 0 (g/l) 18.3±9.3 19.3±13.2 18.1±8.2 1.2 (-1.33 to 3.73) 0.38
Haemoglobin drop until day 1 (g/l) 28.4±10.1 28.4±16.2 28.5±8.4 -0.1 (-3.0–2.8) 0.95
Haemoglobin at day 1 (g/l) 118.46±14.14 103.46±11.04 121.65±12.60 -18.19 (-21.59 to -14.78 <0.001
Knee drain volume (ml)† 209±169 205±162 210±170 -4.8 (-73.4–63.7) 0.89
Length of hospital stay (days) 5 (5–7) 6 (5–8) 5 (5–7) 1 0.01
Any complication 74 (20) 29 (48) 45 (15) 33 (20–46) <0.001
Table 3
Comparison of patients who did or did not receive allogeneic blood transfusion*
more likely to require allogeneic blood transfusion, 
probably owing to a higher percentage of patients 
with preoperative haemoglobin level <120 g/l 
and lower percentage of patients actually received 
salvaged blood. Patients who received allogeneic 
blood transfusion had a longer hospital stay and 
higher complication rate. Those with a preoperative 
haemoglobin level <120 g/l were 30 times more likely 
to require allogeneic blood transfusion (despite the 
use of blood salvage), compared with patients with 
a preoperative haemoglobin level >150 g/l. Thus, 
preoperative optimisation of the haemoglobin level 
to a minimum of 120 g/l is essential.11,25 
 Our study had several limitations. It was 
retrospective and predisposed to recall and selection 
bias. A tourniquet was not used in TKA in order to 
avoid initial decrease in quadriceps strength, swelling, 
and postoperative pain.26 Although tourniquet use 
decreases intra-operative blood loss, total blood loss 
is similar owing to decreased postoperative blood 
loss.27 Patients did not receive any form of tranexamic 
acid; this eliminated the effect of tranexamic acid as a 
confounder of intra-operative blood salvage. Patients 
were allowed to continue taking aspirin during the 
peri-operative period, but this increases the risk of 
major bleeding.28
 Allogeneic blood transfusion is associated 
with an increasing cost of blood banking. Intra-
operative blood salvage combined with preoperative 
optimisation of haemoglobin level, use of tranexamic 
acid, and individualisation of the transfusion trigger 
is recommended.
conclusion
Intra-operative blood salvage is not effective in 
preventing allogeneic blood transfusion in patients 
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